These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16987528)

  • 1. Structural determinants involved in the regulation of CXCL14/BRAK expression by the 26 S proteasome.
    Peterson FC; Thorpe JA; Harder AG; Volkman BF; Schwarze SR
    J Mol Biol; 2006 Nov; 363(4):813-22. PubMed ID: 16987528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An N-terminally truncated mutant of human chemokine CXCL14 has biological activity.
    Neira JL; Sandí MJ; Bacarizo J; Archange C; Camara-Artigas A; Iovanna JL
    Protein Pept Lett; 2013 Aug; 20(8):955-67. PubMed ID: 23270429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of tumour-suppressing chemokine BRAK/CXCL14 reduces cell migration rate of HSC-3 tongue carcinoma cells and stimulates attachment to collagen and formation of elongated focal adhesions in vitro.
    Sato K; Ozawa S; Izukuri K; Kato Y; Hata R
    Cell Biol Int; 2010 Apr; 34(5):513-22. PubMed ID: 20067447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo.
    Shurin GV; Ferris RL; Tourkova IL; Perez L; Lokshin A; Balkir L; Collins B; Chatta GS; Shurin MR
    J Immunol; 2005 May; 174(9):5490-8. PubMed ID: 15843547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear magnetic resonance solution structure of truncated human GRObeta [5-73] and its structural comparison with CXC chemokine family members GROalpha and IL-8.
    Qian YQ; Johanson KO; McDevitt P
    J Mol Biol; 1999 Dec; 294(5):1065-72. PubMed ID: 10600366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR and molecular modeling reveal specificity of the interactions between CXCL14 and glycosaminoglycans.
    Penk A; Baumann L; Huster D; Samsonov SA
    Glycobiology; 2019 Sep; 29(10):715-725. PubMed ID: 31264681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine CXCL14/BRAK transgenic mice suppress growth of carcinoma cell transplants. [corrected].
    Izukuri K; Suzuki K; Yajima N; Ozawa S; Ito S; Kubota E; Hata R
    Transgenic Res; 2010 Dec; 19(6):1109-17. PubMed ID: 20333465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic functions of the CXC-type chemokine CXCL14 in mammals.
    Hara T; Tanegashima K
    J Biochem; 2012 May; 151(5):469-76. PubMed ID: 22437940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells.
    Shellenberger TD; Wang M; Gujrati M; Jayakumar A; Strieter RM; Burdick MD; Ioannides CG; Efferson CL; El-Naggar AK; Roberts D; Clayman GL; Frederick MJ
    Cancer Res; 2004 Nov; 64(22):8262-70. PubMed ID: 15548693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL14 displays antimicrobial activity against respiratory tract bacteria and contributes to clearance of Streptococcus pneumoniae pulmonary infection.
    Dai C; Basilico P; Cremona TP; Collins P; Moser B; Benarafa C; Wolf M
    J Immunol; 2015 Jun; 194(12):5980-9. PubMed ID: 25964486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimeric peptides of the C-terminal region of CXCL14 function as CXCL12 inhibitors.
    Tanegashima K; Tsuji K; Suzuki K; Shigenaga A; Otaka A; Hara T
    FEBS Lett; 2013 Nov; 587(23):3770-5. PubMed ID: 24161674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive expression of CXCL14 in healthy human and murine epithelial tissues.
    Meuter S; Moser B
    Cytokine; 2008 Nov; 44(2):248-55. PubMed ID: 18809336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of proximal promoter of gene for human BRAK/CXCL14, a tumor-suppressing chemokine.
    Komori R; Ozawa S; Kato Y; Shinji H; Kimoto S; Hata R
    Biomed Res; 2010 Apr; 31(2):123-31. PubMed ID: 20460740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and purification of bioactive high-purity recombinant mouse CXCL14 in Escherichia coli.
    Li J; Gao J; Sah S; Satyal U; Zhang R; Han W; Yu Y
    Appl Biochem Biotechnol; 2011 Aug; 164(8):1366-75. PubMed ID: 21431320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a chemokine BRAK/CXCL14 in oral floor carcinoma cells reduces the settlement rate of the cells and suppresses their proliferation in vivo.
    Ito S; Ozawa S; Ikoma T; Yajima N; Kiyono T; Hata R
    Biomed Res; 2010 Jun; 31(3):199-206. PubMed ID: 20622470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of N-C- or C-N-directed sequential native chemical ligation to the preparation of CXCL14 analogs and their biological evaluation.
    Tsuji K; Shigenaga A; Sumikawa Y; Tanegashima K; Sato K; Aihara K; Hara T; Otaka A
    Bioorg Med Chem; 2011 Jul; 19(13):4014-20. PubMed ID: 21658958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human p38 delta MAP kinase mediates UV irradiation induced up-regulation of the gene expression of chemokine BRAK/CXCL14.
    Ozawa S; Ito S; Kato Y; Kubota E; Hata R
    Biochem Biophys Res Commun; 2010 Jun; 396(4):1060-4. PubMed ID: 20478268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses.
    Westrich JA; Vermeer DW; Colbert PL; Spanos WC; Pyeon D
    Mol Carcinog; 2020 Jul; 59(7):794-806. PubMed ID: 32212206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy.
    Starnes T; Rasila KK; Robertson MJ; Brahmi Z; Dahl R; Christopherson K; Hromas R
    Exp Hematol; 2006 Aug; 34(8):1101-5. PubMed ID: 16863917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL14 and insulin action.
    Hara T; Nakayama Y
    Vitam Horm; 2009; 80():107-23. PubMed ID: 19251036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.